Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspirin/AIDS study

This article was originally published in The Tan Sheet

Executive Summary

Community Research Initiative on AIDS plans to conduct a study to examine whether aspirin plays a role in inhibiting HIV. The trial is expected to include 46 randomized, blinded, HIV- positive, asymptomatic people who will take either 1 g aspirin four times daily or acetaminophen as a control. The eight-week study will begin enrolling participants in August. CRIA is negotiating to obtain drug donations and funding for the study. CRIA estimates the cost of the study at about $ 80,000
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081679

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel